These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27793000)

  • 1. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
    Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
    Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms with laryngeal carcinoma prognosis in a Chinese population.
    Quan F; Zhang F; Bai Y; Zhou L; Yang H; Li B; Jin T; Li H; Shao Y
    Oncotarget; 2017 Feb; 8(6):10255-10263. PubMed ID: 28052013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.
    Yang F; Ma H; Feng L; Lian M; Wang R; Fan E; Fang J
    Int J Clin Exp Pathol; 2015; 8(11):13886-99. PubMed ID: 26823701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.
    Yang L; Wang H; Wang Y; He Z; Chen H; Liang S; He S; Wu S; Song L; Chen Y
    Oncotarget; 2016 May; 7(22):31878-91. PubMed ID: 26992242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
    Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
    Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
    Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
    Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
    Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
    Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
    Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
    PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.
    Re M; Zizzi A; Ferrante L; Stramazzotti D; Goteri G; Gioacchini FM; Olivieri F; Magliulo G; Rubini C
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1641-51. PubMed ID: 24402377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
    Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
    Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
    Shen Z; Chen X; Li Q; Zhou C; Li J; Ye H; Duan S
    Diagn Pathol; 2016 Jan; 11():10. PubMed ID: 26796520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
    Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
    Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of HAX-1 expression in laryngeal carcinoma.
    You Y; Yao H; You B; Li X; Ni H; Shi S; Shan Y; Cao X
    Auris Nasus Larynx; 2015 Aug; 42(4):299-304. PubMed ID: 25554539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Neutrophil-to-lymphocyte Ratio Predicts Long-term Survival in Patients Undergoing Total Laryngectomy With Advanced Laryngeal Squamous Cell Carcinoma: A Single-center Retrospective Study.
    Fu Y; Liu W; OuYang D; Yang A; Zhang Q
    Medicine (Baltimore); 2016 Feb; 95(6):e2689. PubMed ID: 26871799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival analysis of laryngeal carcinoma without laryngectomy, radiotherapy, or chemotherapy.
    Yu Q; Zhang X; Ji C; Yang H; Gao M; Hong S; Hu G
    Eur Arch Otorhinolaryngol; 2012 Sep; 269(9):2103-9. PubMed ID: 22186766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
    Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
    Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.
    Tang D; Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Xie M; Cheng L
    Acta Otolaryngol; 2018 Nov; 138(11):1043-1050. PubMed ID: 30776268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic score model incorporating CDGSH iron sulfur domain2 (CISD2) predicts risk of disease progression in laryngeal squamous cell carcinoma.
    Yang L; Hong S; Wang Y; He Z; Liang S; Chen H; He S; Wu S; Song L; Chen Y
    Oncotarget; 2016 Apr; 7(16):22720-32. PubMed ID: 27007153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.